A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
HOLOGIC INC
HOLX
$15.3B
Mkt Cap
HOLOGIC INC (HOLX) has a current P/E ratio of 31.3, compared to its historical median P/E of 20.0. The stock is currently considered Expensive based on its historical valuation range.
HOLOGIC INC (HOLX) has a 5-year average return on invested capital (ROIC) of 19.2%. This indicates strong capital allocation and a potential competitive advantage.
HOLOGIC INC (HOLX) has a market capitalization of $22.8B. It is classified as a large-cap stock.
HOLOGIC INC (HOLX) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 1.03%.
Based on historical P/E analysis, HOLOGIC INC (HOLX) appears expensive. The current P/E of 31.3 is 56% above its historical median of 20.0. The estimated fair value CAGR (P/E method) is 10.8%.
HOLOGIC INC (HOLX) operates in the X-Ray Apparatus & Tubes & Related Irradiation Apparatus industry, within the Healthcare sector.
HOLOGIC INC (HOLX) reported annual revenue of $4.1 billion in its most recent fiscal year, based on SEC EDGAR filings.
Hologic, Inc. is a medical technology company that develops, manufactures, and markets diagnostic and surgical products across multiple healthcare segments. The company operates through a diversified portfolio of businesses serving oncology, women's health, and diagnostic imaging markets, with products ranging from breast imaging systems and molecular diagnostics to surgical instruments and related consumables. Hologic's business model combines capital equipment sales with recurring revenue from consumables, reagents, and service contracts, creating a mix of transactional and subscription-like revenue streams. The company distributes its products globally through direct sales forces, distributors, and healthcare provider relationships, serving hospitals, diagnostic centers, and clinical laboratories. Hologic's competitive positioning is built on proprietary technology platforms, regulatory clearances, and established relationships with healthcare providers across developed and emerging markets.
No forward guidance provided.
Generated solely from the company's own reports listed below — not from third-party data. Hallucination risk is low. · Sources: 10-K
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 4.1B | 4.1B | 4.0B | 4.0B | 4.9B | 5.6B |
| Net Income | 544M | 566M | 790M | 456M | 1.3B | 1.9B |
| EPS | $1.99 | $2.49 | $3.32 | $1.83 | $5.13 | $7.21 |
| Free Cash Flow | 1.0B | 998M | 1.2B | 959M | 2.1B | 2.2B |
| ROIC | 11.0% | 11.0% | 15.9% | 8.6% | 24.2% | 36.4% |
| Gross Margin | 51.5% | 51.6% | 55.3% | 51.4% | 61.6% | 67.4% |
| Debt/Equity | 0.48 | 0.50 | 0.49 | 0.56 | 0.58 | 0.72 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 721M | 714M | 883M | 668M | 1.6B | 2.5B |
| Operating Margin | 17.5% | 17.4% | 21.9% | 16.6% | 33.7% | 44.0% |
| ROE | 10.4% | 11.1% | 15.6% | 9.2% | 28.6% | 54.1% |
| Shares Outstanding | 303M | 227M | 238M | 249M | 254M | 260M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 2.5B | 2.7B | 2.8B | 3.1B | 3.2B | 3.4B | 3.8B | 5.6B | 4.9B | 4.0B | 4.0B | 4.1B | 4.1B |
| Gross Margin | 49.2% | 53.0% | 55.2% | 53.0% | 52.7% | 34.8% | 59.0% | 67.4% | 61.6% | 51.4% | 55.3% | 51.6% | 51.5% |
| R&D | 203M | 215M | 232M | 233M | 219M | 232M | 223M | 276M | 283M | 294M | 273M | 248M | 248M |
| SG&A | 260M | 261M | 267M | 343M | 366M | 332M | 356M | 433M | 408M | 392M | 409M | 449M | 461M |
| EBIT | 280M | 455M | 549M | 1.4B | -238M | -124M | 1.1B | 2.5B | 1.6B | 668M | 883M | 714M | 721M |
| Op. Margin | 11.1% | 16.8% | 19.4% | 44.8% | -7.4% | -3.7% | 29.3% | 44.0% | 33.7% | 16.6% | 21.9% | 17.4% | 17.5% |
| Net Income | 17M | 132M | 331M | 756M | -111M | -204M | 1.1B | 1.9B | 1.3B | 456M | 790M | 566M | 544M |
| Net Margin | 0.7% | 4.9% | 11.7% | 24.7% | -3.5% | -6.0% | 29.5% | 33.2% | 26.8% | 11.3% | 19.6% | 13.8% | 13.2% |
| Non-Recurring | 46M | 29M | 11M | 913M | 700M | 6.6M | 15M | 9.3M | 30M | 4.6M | 47M | 71M | 29M |
| Returns on Capital | |||||||||||||
| ROIC | 3.5% | 6.1% | 8.2% | 16.1% | -2.2% | -4.1% | 23.7% | 36.4% | 24.2% | 8.6% | 15.9% | 11.0% | 11.0% |
| ROE | 0.9% | 6.4% | 15.7% | 30.7% | -4.3% | -9.0% | 46.3% | 54.1% | 28.6% | 9.2% | 15.6% | 11.1% | 10.4% |
| ROA | 0.2% | 1.6% | 4.4% | 9.9% | -1.5% | -3.0% | 16.4% | 23.2% | 14.5% | 5.0% | 8.6% | 6.2% | 5.9% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 508M | 797M | 798M | 8.3M | 733M | 650M | 897M | 2.3B | 2.1B | 1.1B | 1.3B | 1.1B | 1.1B |
| Free Cash Flow | 464M | 749M | 751M | -50M | 675M | 593M | 798M | 2.2B | 2.1B | 959M | 1.2B | 998M | 1.0B |
| Owner Earnings | 250M | 546M | 357M | -447M | 507M | 443M | 690M | 2.1B | 1.9B | 854M | 1.1B | 849M | 152M |
| CapEx | 44M | 48M | 47M | 58M | 58M | 57M | 98M | 118M | 71M | 92M | 72M | 59M | 57M |
| Maint. CapEx | 209M | 192M | 376M | 387M | 161M | 145M | 123M | 130M | 134M | 118M | 129M | 123M | 864M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 209M | 192M | 376M | 387M | 161M | 145M | 123M | 130M | 134M | 118M | 129M | 123M | 864M |
| CapEx/OCF | 8.7% | 6.0% | 5.9% | 696.4% | 8.0% | 8.8% | 11.0% | 5.1% | 3.3% | 8.7% | 5.6% | 5.6% | 5.2% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 250M | 200M | 276M | 200M | 654M | 410M | 542M | 475M | 835M | 753M | 236M |
| Buyback Yield | N/A | N/A | 2.3% | 1.9% | 2.4% | 1.5% | 3.8% | 2.2% | 3.3% | 2.7% | 4.3% | 4.9% | 1.0% |
| Stock-Based Comp | 50M | 59M | 65M | 68M | 65M | 62M | 83M | 65M | 67M | 80M | 82M | 84M | 81M |
| Debt Repayment | 595M | 3.1B | 75M | 84M | 1.4B | 1.5B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | 3.5B | 3.1B | 2.8B | 2.8B | 2.6B | 2.5B | 2.3B | 1.9B | 484M | 96M | 201M | 305M | 144M |
| Cash & Equiv. | 736M | 491M | 548M | 541M | 667M | 602M | 701M | 1.2B | 2.3B | 2.7B | 2.2B | 2.0B | 2.4B |
| Long-Term Debt | 4.2B | 3.2B | 3.0B | 2.2B | 2.7B | 2.8B | 2.7B | 2.7B | 2.8B | 2.5B | 2.5B | 2.5B | 2.5B |
| Debt/Equity | 2.07 | 1.74 | 1.56 | 1.19 | 1.36 | 1.44 | 1.12 | 0.72 | 0.58 | 0.56 | 0.49 | 0.50 | 0.48 |
| Interest Coverage | 1.3 | 2.2 | 3.5 | 8.9 | -1.6 | -0.9 | 9.5 | 26.5 | 17.2 | 6.0 | 7.2 | 6.1 | 6.1 |
| Equity | 2.1B | 2.1B | 2.1B | 2.8B | 2.4B | 2.1B | 2.7B | 4.2B | 4.9B | 5.0B | 5.1B | 5.0B | 5.2B |
| Total Assets | 8.4B | 7.6B | 7.3B | 8.0B | 7.2B | 6.4B | 7.2B | 8.9B | 9.1B | 9.1B | 9.2B | 9.0B | 9.2B |
| Total Liabilities | 6.3B | 5.6B | 5.2B | 5.2B | 4.8B | 4.3B | 4.5B | 4.7B | 4.2B | 4.1B | 4.0B | 4.0B | -17M |
| Intangibles | 3.4B | 3.0B | 2.6B | 2.8B | 2.4B | 1.5B | 1.3B | 1.7B | 1.3B | 889M | 845M | 589M | 547M |
| Retained Earnings | -3.6B | -3.5B | -3.1B | -2.4B | -2.5B | -2.7B | -1.6B | 298M | 1.6B | 2.1B | 2.8B | 3.4B | 3.6B |
| Working Capital | 946M | 322M | 425M | -387M | 321M | 723M | 983M | 1.8B | 2.9B | 3.0B | 2.8B | 2.7B | 2.9B |
| Current Assets | 1.6B | 1.3B | 1.3B | 1.5B | 1.7B | 1.8B | 2.2B | 3.2B | 3.9B | 4.2B | 3.8B | 3.7B | 3.8B |
| Current Liabilities | 620M | 943M | 902M | 1.9B | 1.4B | 1.1B | 1.2B | 1.3B | 938M | 1.2B | 1.0B | 977M | 951M |
| Per Share Data | |||||||||||||
| EPS | 0.06 | 0.45 | 1.16 | 2.64 | -0.40 | -0.76 | 4.21 | 7.21 | 5.13 | 1.83 | 3.32 | 2.49 | 1.99 |
| Owner EPS | 0.87 | 1.87 | 1.25 | -1.56 | 1.82 | 1.65 | 2.61 | 8.23 | 7.58 | 3.43 | 4.52 | 3.74 | 0.50 |
| Book Value | 7.15 | 7.11 | 7.51 | 9.73 | 8.73 | 7.90 | 10.21 | 16.25 | 19.21 | 20.13 | 21.57 | 22.22 | 17.31 |
| Cash Flow/Share | 1.76 | 2.72 | 2.80 | 0.03 | 2.63 | 2.42 | 3.38 | 8.98 | 8.38 | 4.22 | 5.40 | 4.65 | 4.65 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 288.3M | 292.4M | 285.2M | 286.2M | 278.3M | 267.9M | 264.9M | 259.6M | 253.8M | 249.2M | 237.8M | 227.2M | 302.9M |
| Valuation | |||||||||||||
| P/E Ratio | 406.0 | 83.9 | 33.4 | 13.9 | N/A | N/A | 15.6 | 10.1 | 12.7 | 38.3 | 24.3 | 27.0 | 37.9 |
| P/FCF | 15.1 | 14.7 | 14.7 | N/A | 16.9 | 22.4 | 21.8 | 8.6 | 8.1 | 18.2 | 15.8 | 15.3 | 21.9 |
| EV/EBIT | 37.7 | 31.2 | 25.2 | 9.7 | N/A | N/A | 17.9 | 8.4 | 10.4 | 26.3 | 22.0 | 21.8 | 31.8 |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 4.4 |
| Price/Sales | 2.6 | 3.5 | 3.7 | 3.8 | 3.4 | 3.6 | 3.7 | 3.3 | 3.8 | 4.8 | 4.4 | 3.8 | 5.5 |
| FCF Yield | 6.6% | 6.8% | 6.8% | -0.5% | 5.9% | 4.5% | 4.6% | 11.7% | 12.4% | 5.5% | 6.3% | 6.5% | 4.6% |
| Market Cap | 7.0B | 11.0B | 11.0B | 10.5B | 11.4B | 13.3B | 17.4B | 18.9B | 16.6B | 17.5B | 19.2B | 15.3B | 22.8B |
| Avg. Price | 23.08 | 32.81 | 36.56 | 40.97 | 39.78 | 45.41 | 52.49 | 72.06 | 72.22 | 77.22 | 74.76 | 67.76 | 75.36 |
| Year-End Price | 24.36 | 37.76 | 38.73 | 36.65 | 40.98 | 49.61 | 65.77 | 72.87 | 65.23 | 70.05 | 80.82 | 67.21 | 75.36 |
HOLOGIC INC passes 4 of 9 quality checks, suggesting mixed fundamentals.
HOLOGIC INC trades at 31.3x trailing earnings, compared to its 15-year median P/E of 20.0x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 16.2x vs a median of 15.8x. The company's 5-year average ROIC is 19.2% with a gross margin of 57.5%. Total shareholder yield (buybacks) is 1.0%. At current prices, the estimated annualized return to fair value is +12.5%.
HOLOGIC INC (HOLX) has a net profit margin of 13.8%. This is a healthy margin.
HOLOGIC INC (HOLX) generated $998 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
HOLOGIC INC (HOLX) has a debt-to-equity ratio of 0.50. This indicates a conservatively financed balance sheet.
HOLOGIC INC (HOLX) reported earnings per share (EPS) of $2.49 in its most recent fiscal year.
HOLOGIC INC (HOLX) has a return on equity (ROE) of 11.1%. This indicates moderate shareholder returns.
HOLOGIC INC (HOLX) has a 5-year average gross margin of 57.5%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 19 years of financial data for HOLOGIC INC (HOLX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
HOLOGIC INC (HOLX) has a book value per share of $22.22, based on its most recent annual SEC filing.